Lactulose Ammonia Binding for Autism Neurotoxicity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for autism are limited to behavioral and educational solutions, failing to address the physiological and gastrointestinal issues associated with ammonia buildup in the gastrointestinal tract, bloodstream, and nervous system, particularly exacerbated by antibiotics like Augmentin®, which can lead to neurotoxicity.

Innovation Solution

Lactulose is used to bind and reduce ammonia levels in the gastrointestinal tract, bloodstream, and nervous system by fermenting in the colon, promoting beneficial bacteria growth and lowering serum ammonia levels, thereby reversing ammonia poisoning effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If antibiotics like Augmentin are used to treat infections in autistic children, then infections are reduced, but ammonia residue builds up in the gastrointestinal tract leading to neurotoxicity

Engineering Contradiction:
ImproveinfectionVSAvoidammonia residue
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful ammonia residue produced by antibiotic use into a beneficial outcome by using lactulose to trap the ammonia in the colon, preventing its absorption into the bloodstream and brain, thereby eliminating the neurotoxicity while maintaining the infection-fighting benefits of antibiotics

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

Lactulose acts as an intermediary substance between the antibiotic-induced ammonia production and the bloodstream/brain, binding the ammonia in the colon and preventing it from reaching sensitive tissues, thus mediating the harmful interaction

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If behavioral and educational solutions are used for autism treatment, then social and communication skills are improved, but physiological and gastrointestinal problems are not addressed

Engineering Contradiction:
Improvebehavioral interventionVSAvoidgastrointestinal issues
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent applies lactulose to address multiple aspects of autism simultaneously - it treats gastrointestinal problems by reducing ammonia in the colon while also addressing neurological symptoms by preventing ammonia-induced neurotoxicity, thus providing a multi-functional treatment approach

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Quantity of substance

If high doses of lactulose are used for hepatic encephalopathy, then serum ammonia levels are reduced, but the treatment mechanism is not applied to autism

Engineering Contradiction:
Improveammonia reductionVSAvoidtreatment application
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The patent extends the use of lactulose from its established application in hepatic encephalopathy to the treatment of autism, demonstrating the versatility of this substance in addressing ammonia-related neurological conditions across different disease contexts

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Lactulose effectively decreases ammonia levels, reducing neurotoxicity and addressing the physiological symptoms of autism, providing a treatment that complements existing behavioral interventions by targeting the underlying gastrointestinal issues.

Implementation Method 1

The efficacy of lactulose in these conditions is based on its fermentation in the colon by certain bacteria

Methodology Applied
Scientific EffectFermentation: Fermentation

Implementation Method 2

The products of fermentation are mainly organic acids, such as lactic acid and small-chain fatty acids, which, by exerting a local osmotic effect in the colon, result in increased fecal bulk and stimulation of peristalsis

Methodology Applied
Scientific EffectOsmotic effect: Osmotic Pressure

Implementation Method 3

The higher doses used for hepatic encephalopathy lower the colonic pH, and ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis

Methodology Applied
Scientific EffectpH lowering:

Implementation Method 4

ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis

Methodology Applied
Scientific EffectAmmonium ion formation:

Implementation Method 5

Lactulose is used to bind ammonia in the gastrointestinal tract, the bloodstream, and the nervous system

Methodology Applied
Scientific EffectAmmonia binding: Absorption (physical)

Data Source

PatentUS11033563B2Use of lactulose in the treatment of autism
Publication Date: 2021.06.15 CUREMARK LLC
  • US11033563B2 patent drawing
  • US11033563B2 patent drawing

AI summary

A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria. The fermentation process lowers the colonic pH, and ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis. This lowers the serum ammonia levels and reduces neurotoxicity.